SCHEMBL4176458

SCHEMBL4176458

Cc1c(Cl)cccc1S(=O)(=O)NCc1cccc(C(=O)NCc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
RAB9A P51151 1/20 0.57
ALDH1A1 P00352 2/20 0.51
MRGPRX4 Q96LA9 1/20 0.51
NSD2 O96028 2/20 0.48
HTT P42858 2/20 0.48
MAPT P10636 3/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
PLA2G1B P04054 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ATG4B Q9Y4P1 1/20 0.47
TP53 P04637 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3872896 0.87 LMNA (0.52) LMNARAB9AALDH1A1HTTMAPT
SCHEMBL3884734 0.86 MAPT (0.51) LMNARAB9AALDH1A1HTTMAPT
SCHEMBL3874145 0.79 FABP4 (0.56) LMNAMRGPRX4GAATDP1TP53
SCHEMBL3872261 0.78 ALDH1A1 (0.56) LMNAALDH1A1HTTMAPTMEN1
SCHEMBL3873274 0.78 FABP4 (0.49) ALDH1A1MRGPRX4MAPTGAATP53
SCHEMBL3876258 0.75 HSD11B1 (0.56) LMNARAB9AALDH1A1HTTMAPT
SCHEMBL3876675 0.75 HSD11B1 (0.53) LMNARAB9AALDH1A1HTTMAPT
SCHEMBL3874658 0.74 ROCK2 (0.47) LMNARAB9AALDH1A1MAPTMEN1
SCHEMBL3872528 0.72 MMP13 (0.50) LMNARAB9AALDH1A1MAPTMEN1
SCHEMBL3872830 0.71 ROCK2 (0.46) LMNARAB9AALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069323-A1 11beta-hsdi inhibitors EVOTEC AG (DE) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069323-A1 11beta-hsdi inhibitors HSD3B1, HSD3B2, HSD11B1 LMNA 2473/4885RAB9A 4300/4885ALDH1A1 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.